메뉴 건너뛰기




Volumn 12, Issue 5, 2001, Pages 633-641

The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

Author keywords

Docetaxel; Estramustine; Hormone refractory prostate cancer; Quality of life

Indexed keywords

DOCETAXEL; ESTRAMUSTINE; HORMONE; HYDROCORTISONE; NARCOTIC ANALGESIC AGENT;

EID: 0034986608     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011102619058     Document Type: Article
Times cited : (46)

References (38)
  • 1
    • 0032784113 scopus 로고    scopus 로고
    • Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: Results of the Cancer and Leukemia Group B 9182 study
    • (1999) J Clin Oncol , vol.17 , pp. 2506-2513
    • Kantoff, P.W.1    Halabi, S.2    Conaway, M.3
  • 6
    • 0032995544 scopus 로고    scopus 로고
    • Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone-refractory prostate cancer
    • (1999) Ann Oncol , vol.10 , pp. 33-38
    • Kreis, W.1    Budman, D.R.2    Fetten, J.3
  • 10
    • 0003348272 scopus 로고    scopus 로고
    • Phase II trial of single-agent weekly (wk) Taxotere (T) in symptomatic, hormone-refractory prostate cancer (HRPC)
    • and the American Oncology Resources Clinical Research Task Force. (Abstr 1290).
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Berry, W.1    Rohrbaugh, T.2
  • 11
    • 0033406349 scopus 로고    scopus 로고
    • A Phase II trial of docetaxel (taxotere) in hormone-refractory prostate cancer: Correlations of antitumor effect to phosphorylation of BCL-2
    • (1999) Semin Oncol , vol.26 , Issue.SUPPL. 17 , pp. 19-23
    • Friedland, D.1    Cohen, J.2    Miller R., Jr.3
  • 22
    • 0033457887 scopus 로고    scopus 로고
    • A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of Cancer and Leukemia Group B trial 9780
    • (1999) Semin Oncol , vol.26 , Issue.SUPPL. 17 , pp. 39-44
    • Savarese, D.1    Taplin, M.E.2    Halabi, S.3
  • 24
    • 0031449904 scopus 로고    scopus 로고
    • Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy - Prostate (FACT-P) instrument
    • (1997) Urology , vol.50 , pp. 920-928
    • Esper, P.1    Mo, F.2    Chodak, G.3
  • 25
    • 0004908036 scopus 로고
    • Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, North Carolina: Duke University Press
    • (1992)
    • Stewart, A.L.1    Ware J.E., Jr.2
  • 31
    • 0004909672 scopus 로고
    • Multidimensional functional assessment of older adults: The Duke Older Americans Resources and Services Procedures. Hilldale, New Jersey: Lawrence Erlbaum Associates
    • (1988)
    • Fillenbaum, G.G.1
  • 35
    • 0004844473 scopus 로고    scopus 로고
    • A phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780
    • Manuscript submitted.
    • Savarese, D.1    Halabi, S.2    Hars, V.3
  • 38
    • 0000172739 scopus 로고    scopus 로고
    • Mutuality of fate: Adaptation and psychological distress in cancer patients and their partners
    • Baider L, Cooper CL, Cooper CL, Kaplan De-Nour A (eds): Chichester, UK: John Wiley & Sons
    • (1996) Cancer and the Family , pp. 173-186
    • Baider, L.1    Kaufman, B.2    Peretz, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.